Shortening the Diagnostic Odyssey
RARECast - Un podcast de RARECast - Les jeudis
Catégories:
Katherine Stueland, CEO of GeneDx, discusses the state of genetic testing, what its 2022 acquisition by the AI-drive genomics company SEMA4 has meant to it, and what she thinks it will take to make meaningful change to the diagnostic odyssey.
